InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Castelein Caley, Director. Director active across 4 companies, notably ViewRay, Inc.. Aggregated, 15 filings have been logged. Split: 3 buys · 1 sell. Total volume traded: €3.8m. Activity tracked since 14 June 2021. The latest transaction was disclosed on 15 October 2025 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Castelein Caley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
515,997 sharesCommon StockSEC:0001355758-25-000006:0
431,939 sharesCommon StockSEC:0001355758-25-000006:1
522 shares0Common StockSEC:0001355758-25-000004:0
1,666,000 shares@ US$2.4030.0% of flowCommon StockSEC:0001415889-25-006742:0
4,200 shares@ US$12.07100.0% of flowCommon StockSEC:0001209191-23-053791:0
Canonical exit: 23 Jan 2024 (T+90)
496,519 sharesCommon StockSEC:0001209191-23-053389:0
158,397 shares@ US$0.0680.9% of flowCommon StockSEC:0001628280-23-025331:0
16,590 shares@ US$4.406.4% of flowCommon StockSEC:0001628280-23-000250:0
240,000 shares@ US$12.5024.5% of flowCommon StockSEC:0001209191-22-051391:0
54,511 shares0Common StockSEC:0001628280-22-017230:0
350,000 shares@ US$2.570485.7% of flowCommon StockSEC:0001628280-22-014015:0
Canonical exit: 8 Aug 2022 (T+90)
12,521 shares@ US$5.836.4% of flowCommon StockSEC:0001628280-22-000344:0
259,998 shares@ US$13.07729.4% of flowCommon StockSEC:0000899243-21-034553:0
Canonical exit: 24 Nov 2021 (T+90)
7,811 shares@ US$1.52100.0% of flowCommon StockSEC:0000899243-21-027286:0
19,759 shares0Common StockSEC:0001209191-21-040911:0
15 of 15 declarations
About Castelein Caley
Castelein Caley is Administrateur and has filed 15 forms in total. In the sampled recent filings between 2021-06-16 and 2025-10-28, the reported amounts are EUR 3794126 in buys and EUR 9612 in sells, with transactions involving Aadi Bioscience, Inc., ViewRay, Inc. and the other listed companies.
